Targeting S100A8/A9: a molecular gateway to oral inflammation, microglial activation and neuroinflammation.

Malik JA, Qamar T, Qadri AH, Faheem I

Open source

DOI
10.3389/fimmu.2026.1888031
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1888031,
  title = {Targeting S100A8/A9: a molecular gateway to oral inflammation, microglial activation and neuroinflammation.},
  author = {Malik JA and Qamar T and Qadri AH and Faheem I},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1888031},
  url = {https://doi.org/10.3389/fimmu.2026.1888031}
}

RIS

TY  - JOUR
TI  - Targeting S100A8/A9: a molecular gateway to oral inflammation, microglial activation and neuroinflammation.
AU  - Malik JA
AU  - Qamar T
AU  - Qadri AH
AU  - Faheem I
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1888031
UR  - https://doi.org/10.3389/fimmu.2026.1888031
ER  - 

APA

JA, M., T, Q., AH, Q., & I, F. (2026). Targeting S100A8/A9: a molecular gateway to oral inflammation, microglial activation and neuroinflammation.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1888031

Source records